Immediate Impact
4 from Science/Nature 64 standout
Citing Papers
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Standout
Works of Lydia Ferguson being referenced
Phase Ib trial of ALT-803, an IL-15 superagonist, plus BCG for the treatment of BCG-naïve patients with non-muscle-invasive bladder cancer.
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Lydia Ferguson | 106 | 170 | 144 | 139 | 14 | 347 | |
| Darlene M. Redenbach | 68 | 152 | 74 | 166 | 16 | 410 | |
| Yi Ting Tsai | 44 | 192 | 113 | 159 | 11 | 406 | |
| TAKAFUMI YAMAZAKI | 61 | 141 | 89 | 266 | 11 | 350 | |
| N. E. Skakkeb�k | 107 | 164 | 115 | 74 | 13 | 396 | |
| Rachel D. Mullen | 34 | 214 | 157 | 70 | 15 | 384 | |
| Rachel A. Jesudasan | 23 | 200 | 93 | 155 | 17 | 395 | |
| Bérangère Legois | 30 | 214 | 134 | 151 | 12 | 347 | |
| Erina Inoue | 31 | 292 | 90 | 54 | 14 | 383 | |
| Masaki Dobashi | 73 | 156 | 94 | 308 | 14 | 393 | |
| Nicole Morichon | 73 | 162 | 149 | 81 | 10 | 359 |
All Works
Loading papers...